Month: March 2026

JUPITER, Fla., March 16, 2026 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, food and nutrition, and bioindustrial applications today announced that it has entered into an original equipment manufacturer (“OEM”) distribution agreement with Integrated Biotherapeutics, LLC, d/b/a IBT Bioservices (“IBT”), a life sciences reagent manufacturer and distributor serving global research markets. Through this collaboration, Dyadic-produced recombinant protein products will be commercialized through IBT’s established sales channels, expanding market access and supporting Dyadic’s objective of generating ongoing, product-based revenues. The initial products expected...

16 March 2026 LEI: 2138003QW2ZAYZODBU23 LSE Code: 3OIS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland) WISDOMTREE WTI CRUDE OIL 3X DAILY SHORT SECURITIES ISIN: XS2819844387 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES MEETING OF THE ETP SECURITYHOLDERS THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. NOTICE is hereby given that, pursuant to the provisions of the trust deed dated 30 November 2012 (as amended) constituting (inter alia) the WisdomTree WTI Crude Oil 3x Daily Short Securities (the “Affected Securities”) and made between (1) WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”),...

Costa Mesa, CA, March 16, 2026 (GLOBE NEWSWIRE) — Real Messenger Corporation (“Real Messenger” or the “Company”) (Nasdaq: RMSG), an innovative chat-based platform reimagining real estate connections, today announced that it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated March 13, 2026, notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company’s class A ordinary shares was below $1 per share for the last 30 consecutive business days (i.e. from January 29, 2026 to March 12, 2026). The Nasdaq Letter is only a notification of deficiency. It does not result in the immediate delisting and has no current effect on the listing or trading of the...

CARLSBAD, Calif., March 16, 2026 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced it will participate in the 38th Annual ROTH Conference on March 22-24, hosted by Roth Capital Partners. The conference will be held March 22-24, 2026 at the Ritz-Carlton in Laguna Niguel, California and the management team will be available for one-on-one meetings with investors at the conference. Investors attending the conference who are interested in scheduling a meeting with management, can do so by contacting their Roth representative, or by emailing asapf@lythampartners.com. About the Roth Capital Partners Conference The Annual ROTH Conference is one of the largest in...

Company announcement no. 21/2026 With reference to release no. 18 of today, the capital increase has now been registered at the Danish Business Authority. Hereafter, the share capital of Columbus A/S amounts to DKK 162,157,830 (nom.) divided into 129,726,264 shares of DKK 1.25. The total number of votes is 129,726,264. New Articles of Association are attached. Ib Kunøe                                     Søren Krogh KnudsenChairman of the Board                CEO & PresidentFor further information, please contact: CEO & President, Søren Krogh Knudsen, Tel : +45 70 20 50 00AttachmentArticles of Association 160326

Nanterre, March 16, 2026 Declaration of transactions on treasury shares(period from 9 to 13 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 9 and 13, 2026 (ISIN code FR0004050250):Day Total daily volume(in number of shares) Weighted average price(unit daily)03/12/2026 25,669 €36.1003/13/2026 6,734 €34.96Total 32,403  As of March 13, 2026, excluding the liquidity contract, NEURONES now holds 42,892 of the 24,328,716 shares comprising the company’s capital (i.e., 0.18%). All press releases relating to the share buyback program are published in the “Regulated Information” section (under “Weekly declarations of the share buyback transactions” and “Share buyback programs”)...